Opportunity to Participate in a Survey on HIV Cure Research

There has been an increase in HIV cure-related research in the recent years. Many approaches are being investigated in the United States and other countries. Go to the survey here: http://bit.ly/2DoCx8e. The Gillings School of Global Public Health at UNC and Project Inform would like to find…Read More

Dana Van Gorder Departing After Decade of Leadership at Project Inform

The Board of Directors of Project Inform is announcing today the upcoming departure of Dana Van Gorder as Executive Director on June 30, 2018, after successfully leading Project Inform for over 10 years. With the upcoming leadership transition, the Board has appointed David Evans to the…Read More

California Governor Jerry Brown’s Budget is Model for Hepatitis C Funding

Reprinted from HepMag.com. On Friday, May 11, 2018, Governor Jerry Brown of California released his “May Revised Budget” and it contained a lot of excellent news for people living with hepatitis C (HCV): Called for the removal of all fibrosis restrictions in Medi-Cal; Added $70.4 million…Read More

Statement on Potential Safety Signal in Infants Born to Women Taking Dolutegravir from the HHS Antiretroviral Guideline Panels

Date: May 18, 2018, reprinted from AIDSinfo The HHS Antiretroviral Guidelines Panels1 are issuing this statement in response to a potential safety signal in infants born to women who were taking dolutegravir (DTG)-based antiretroviral (ARV) drug regimens at the time of conception in accordance with guidance…Read More

CA Governor’s new budget increases investment in expanding hepatitis C treatment

FOR IMMEDIATE RELEASE:  MAY 15, 2018  (CLICK HERE FOR PDF) CONTACT: ANNE DONNELLY, adonnelly AT projectinform DOT org, (415) 640-6103 ANDREW REYNOLDS areynolds AT projectinform DOT org, (415) 312-3445 SAN FRANCISCO, CA – Project Inform and the California Hepatitis Alliance (CalHEP), a group of over 100…Read More

New HIV medication ibalizumab (Trogarzo) approved by the FDA for people with few treatment options

On March 6, 2018, the FDA approved a new type of HIV medication called ibalizumab for people who have few to no treatment options due to multi-drug resistant virus. The approval was based on results from the TMB-301 study that showed that adding the drug to…Read More

New information reflected in Project Inform’s updated PrEP flow chart

Project Inform has recently updated our Getting Yourself Prepared for PrEP flow chart to reflect a few new changes in the information: Gilead increased their Co-pay Coupon Card program assistance limit to $4,800 on January 1, 2018, from the previous amount of $3,600. The FPL (Federal…Read More